Seronegative antibody‐mediated neurology after immune checkpoint inhibitors

Checkpoint inhibitor medications have revolutionized oncology practice, but frequently induce immune‐related adverse events. During autoimmune neurology practice over 20 months, we prospectively identified four patients with likely antibody‐mediated neurological diseases after checkpoint inhibitors:...

詳細記述

書誌詳細
主要な著者: Wilson, R, Menassa, D, Davies, A, Michael, S, Hester, J, Kuker, W, Collins, G, Cossins, J, Beeson, D, Steven, N, Maddison, P, Rinaldi, S, Jacob, S, Irani, S
フォーマット: Journal article
出版事項: Wiley 2018